Search clinical trials for: everolimus and letrozole
Total 272133 results
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaboratorsCompletedFibrolamellar Carcinoma | Fibrolamellar Liver CancerUnited States
-
Sinai Hospital of BaltimoreUnknownOvarian Cancer | Endometrial CancerUnited States
-
Seung-Jung ParkAbbott Medical Devices; CardioVascular Research Foundation, KoreaTerminatedCoronary Artery DiseaseThailand, Korea, Republic of, China, Malaysia
-
Novartis PharmaceuticalsCompletedBreast NeoplasmUnited States, Germany, Spain, United Kingdom, France, Austria, Russian Federation, Italy, Canada, Belgium
-
University of Maryland, BaltimoreGlaxoSmithKline; Novartis PharmaceuticalsTerminatedBreast Neoplasms | Neoplasm Metastasis | Endocrine Breast DiseasesUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisActive, not recruiting
-
Gynaecologisch Oncologisch Centrum ZuidRadboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaboratorsRecruitingRecurrent Ovarian Cancer | Therapy-Associated Cancer | Signal Transduction Pathway DeregulationNetherlands
-
The Netherlands Cancer InstituteActive, not recruitingNeuroendocrine CarcinomasNetherlands
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
German Breast GroupNovartisTerminatedMetastatic Breast CancerGermany
-
Helsinki University Central HospitalFoundation for Paediatric Research, FinlandCompletedConstitutional Delay of Growth and PubertyFinland
-
Novartis PharmaceuticalsCompletedLymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain
-
University of LuebeckTerminatedCoronary Artery DiseaseGermany
-
Novartis PharmaceuticalsTerminatedCarcinoma, Renal CellAustralia, Korea, Republic of
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
Guangdong Provincial People's HospitalNovartisUnknownNeuroendocrine Tumors | Carcinoid TumorChina
-
Sinai Hospital of BaltimoreUnknown
-
Leiden University Medical CenterUnknownHead and Neck CancerNetherlands
-
ARCAGY/ GINECO GROUPCompletedEndometrial CancerFrance
-
Rovi Pharmaceuticals LaboratoriesRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Dana-Farber Cancer Institute; Novartis PharmaceuticalsCompletedMalignant Pleural MesotheliomaUnited States
-
Asan Medical CenterCompletedStomach NeoplasmKorea, Republic of
-
Samsung Medical CenterCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminated
-
Centre Leon BerardSuspended
-
Umberto I Hospital, Frosinone ItalyUnknownAcute Myocardial Infarction | Artery; Deformity, Coronary (Acquired)Italy
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaChina
-
Asan Medical CenterCompletedStomach NeoplasmKorea, Republic of
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
Bayside HealthUnknownAcute Myeloid LeukemiaAustralia
-
Abbott Medical DevicesCompletedAtherosclerosis | Peripheral Vascular DiseaseGermany, Austria, Belgium, Italy
-
Greater Baltimore Medical CenterCompleted
-
Yonsei UniversityUnknown
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
Dana-Farber Cancer InstituteNovartis; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedGlioma | Astrocytoma | Low-grade GliomaUnited States
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
Cardiff UniversityNovartisUnknownTuberous SclerosisUnited Kingdom
-
Julie E. Bauman, MD, MPHNovartisTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Germany
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Institut du Cancer de Montpellier - Val d'AurelleNovartisCompleted
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbHCompletedNeuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditionsGermany
-
Radboud University Medical CenterNovartisCompletedBreast NeoplasmsNetherlands
-
Novartis PharmaceuticalsCompleted
-
Hopital FochCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
Dana-Farber Cancer InstituteM.D. Anderson Cancer Center; Massachusetts General Hospital; Novartis; MOUNT SINAI...Completed